Invitation: Actelion to discuss first quarter 2016 financial results

Invitation: Actelion to discuss first quarter 2016 financial results

ID: 464145

(Thomson Reuters ONE) -
Actelion Pharmaceuticals Ltd /
Invitation: Actelion to discuss first quarter 2016 financial results
. Processed and transmitted by NASDAQ OMX Corporate Solutions.
The issuer is solely responsible for the content of this announcement.

Dear member of the investment community,

Actelion Ltd will announce its first quarter 2016 financial results on Thursday,
21 April 2016, at 07:00 hrs CEST.
An investor conference call and webcast will be held at 15:00 hrs CEST to
discuss the results.

To support your preparations, consensus estimates can be found under
www.actelion.com/consensus-estimate

Date/Time:



21 April 2016 15:00 hrs - 16:00 hrs Basel

  14:00 hrs - 15:00 hrs London

  09:00 hrs - 10:00 hrs New York



Conference Call Connect #:
Dial-in participants should start calling the number below 10-15 minutes before
the conference is due to start.

Dial: Europe: +41 (0)44 583 18 01

  UK: +44 (0)203 009 24 53

  US: +1 855 402 77 68



Participant's mode:
Listen-Only with possibility to open individual lines during Q&A session.
Participants will be asked for their name and company.

Webcast Access:
Webcast participants should go to the Actelion website http://www.actelion.com
10-15 minutes before the conference is due to start.

Participant's mode: Listen-Only

Webcast Replay:
The archived Investor Webcast will be available for replay through
http://www.actelion.com/  approximately 60 minutes after the call has ended.

Actelion Pharmaceuticals Ltd
Investor Relations
Gewerbestrasse 16 | CH-4123 Allschwil | Switzerland | phone +41 61 565 62 62 |
fax +41 61 565 65 07
investor.relations(at)actelion.com | www.actelion.com




 

Invitation PDF:
http://hugin.info/131801/R/2003599/739613.pdf



This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: Actelion Pharmaceuticals Ltd via GlobeNewswire
[HUG#2003599]




Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  ING sells remaining stake in NN Group Coface SA announces the publication of its 2015 Registration Document
Bereitgestellt von Benutzer: hugin
Datum: 14.04.2016 - 17:35 Uhr
Sprache: Deutsch
News-ID 464145
Anzahl Zeichen: 2696

contact information:
Town:

Allschwil



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 270 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Invitation: Actelion to discuss first quarter 2016 financial results"
steht unter der journalistisch-redaktionellen Verantwortung von

Actelion Pharmaceuticals Ltd (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Actelion Pharmaceuticals Ltd



 

Werbung



Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z